Medicare Part D coverage · efinaconazole · RxCUI 1539762
efinaconazole 100 MG/ML Topical Solution [Jublia]
Per the CMS 2026 Part D formulary file, efinaconazole 100 MG/ML Topical Solution [Jublia] is covered by 971 Medicare Part D plans (19.2% of enrollable products), averaging Tier 4.5, with prior authorization required on 8.3% of covering formularies.
- 19.2%
- Plan coverage
- 971
- Plans covering
- T4.5
- Avg tier
- 8.3%
- Prior auth required
What the CMS Formulary Data Shows for efinaconazole 100 MG/ML Topical Solution [Jublia]
Per the CMS 2026 Part D formulary file, efinaconazole 100 MG/ML Topical Solution [Jublia] (RxNorm concept RXCUI 1539762, generic name efinaconazole) appears on 24 distinct formulary files spanning 971 Medicare Part D plan offerings - 19.2% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.5.
Real-world access to efinaconazole 100 MG/ML Topical Solution [Jublia] depends on utilization management as much as tier placement: 8.3% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 28,671 Part D beneficiaries filled efinaconazole 100 MG/ML Topical Solution [Jublia] in 2023, with total plan-and-beneficiary spending of $93,684,777 and an average per-beneficiary annual cost of $3,267.58. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry efinaconazole 100 MG/ML Topical Solution [Jublia] today.
Coverage Details
- Formularies covering
- 24
- Plans covering
- 971
- Coverage rate
- 19.2%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 5, Specialty
Restrictions
- Prior authorization required
- 8.3% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 28,671
- Total spending
- $93,684,777
- Avg per beneficiary
- $3,267.58
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering efinaconazole 100 MG/ML Topical Solution [Jublia]
5 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T4 | No | No | $0 | - |
| AARP Medicare Rx Preferred from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T4 | No | No | $0 | - |
| AARP Medicare Rx Saver from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T4 | No | No | $0 | - |
| AARP Medicare Rx Saver from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T4 | No | No | $0 | - |
| AARP Medicare Rx Saver from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T4 | No | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering efinaconazole 100 MG/ML Topical Solution [Jublia]
95 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Provider Partners Pennsylvania Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Pennsylvania, Inc | T1 | No | $0 | PA |
| Provider Partners North Carolina Community Plan (HMO I-SNP) | Provider Partners Health Plan OF North Carolina | T1 | No | $0 | NC |
| Provider Partners Indiana Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Indiana | T1 | No | $0 | IN |
| Provider Partners Missouri Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Missouri, Inc. | T1 | No | $0 | MO |
| Provider Partners Texas Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Texas, Inc. | T1 | No | $4.80 | TX |
| Provider Partners Illinois Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Illinois | T1 | No | $15.20 | IL |
| Provider Partners Pennsylvania Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Pennsylvania, Inc | T1 | No | $32.70 | PA |
| Provider Partners Pennsylvania Essential Plan (HMO I-SNP) | Provider Partners Health Plan OF Pennsylvania, Inc | T1 | No | $32.70 | PA |
| Provider Partners North Carolina Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF North Carolina | T1 | No | $36.20 | NC |
| Provider Partners North Carolina Essential Plan (HMO I-SNP) | Provider Partners Health Plan OF North Carolina | T1 | No | $36.20 | NC |
| Provider Partners Indiana Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Indiana | T1 | No | $38.40 | IN |
| Provider Partners Indiana Essential Plan (HMO I-SNP) | Provider Partners Health Plan OF Indiana | T1 | No | $38.40 | IN |
| Provider Partners Kentucky Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Kentucky | T1 | No | $38.40 | KY |
| Provider Partners Missouri Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Missouri, Inc. | T1 | No | $43.00 | MO |
| Provider Partners Missouri Essential Plan (HMO I-SNP) | Provider Partners Health Plan OF Missouri, Inc. | T1 | No | $43.00 | MO |
| UHC Dual Complete IA-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T4 | No | $0 | IA |
| UHC Dual Complete MO-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T4 | No | $0 | MO |
| UHC Dual Complete NE-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T4 | No | $0 | NE |
| UHC Dual Complete KS-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T4 | No | $0 | KS |
| UHC Dual Complete MO-S3 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T4 | No | $0 | MO |
Show the next 30 plans
Showing top 50 of 95 plans.
Frequently Asked Questions
Is efinaconazole 100 MG/ML Topical Solution [Jublia] covered by Medicare Part D?
Yes, efinaconazole 100 MG/ML Topical Solution [Jublia] is covered by 971 Medicare Part D plans (19.2% of all Part D formularies).
What tier is efinaconazole 100 MG/ML Topical Solution [Jublia] on Medicare Part D plans?
efinaconazole 100 MG/ML Topical Solution [Jublia] averages Tier 4.5 across Part D plans, ranging from Tier 1 to Tier 5.
Does efinaconazole 100 MG/ML Topical Solution [Jublia] require prior authorization?
8.3% of Part D formularies require prior authorization for efinaconazole 100 MG/ML Topical Solution [Jublia]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on efinaconazole 100 MG/ML Topical Solution [Jublia]?
In 2023, total Medicare Part D spending on efinaconazole 100 MG/ML Topical Solution [Jublia] was $93,684,777, covering 28,671 beneficiaries. The average spend per beneficiary was $3,267.58.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- risperidone 37.5 MG Injection [Risperdal] T4.5
- deflazacort 6 MG Oral Tablet T4.5
- letermovir 20 MG Oral Pellet [Prevymis] T4.5
- tedizolid phosphate 200 MG Injection [Sivextro] T4.5
- 0.5 ML tbo-filgrastim 0.6 MG/ML Prefilled Syringe [Granix] T4.5
- 0.8 ML tbo-filgrastim 0.6 MG/ML Prefilled Syringe [Granix] T4.5
Similar prior-authorization rate
- alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet 8.3% PA
- 100 ML levofloxacin 5 MG/ML Injection 8.3% PA
- lanthanum carbonate 750 MG Chewable Tablet 8.3% PA
- estrogens, conjugated (USP) 1.25 MG Oral Tablet [Premarin] 8.3% PA
- estrogens, conjugated (USP) 0.625 MG Oral Tablet [Premarin] 8.3% PA
- prednisolone 30 MG Disintegrating Oral Tablet 8.3% PA